InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-19.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Grainger David J, Responsable de l'Innovation. Officer active across 1 company, notably Centessa Pharmaceuticals plc. In total, 10 disclosures have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €233k. History available since 28 January 2022. The latest transaction was filed on 31 December 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Grainger David J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
4,700 shares@ US$7.965.7% of flowOrdinary SharesSEC:0001847903-24-000011:0
4,700 shares@ US$6.474.8% of flowOrdinary SharesSEC:0001847903-23-000177:0
4,290 shares@ US$5.90013.9% of flowOrdinary SharesSEC:0001847903-23-000142:0
4,825 shares@ US$3.902.9% of flowOrdinary SharesSEC:0001847903-23-000081:0
77,200 shares0Ordinary SharesSEC:0001847903-23-000048:0
7,154 shares@ US$4.255.2% of flowOrdinary SharesSEC:0001847903-23-000029:0
2,497 shares@ US$3.101.2% of flowOrdinary SharesSEC:0001847903-23-000011:0
2,328 shares@ US$4.06741.6% of flowOrdinary SharesSEC:0001847903-22-000067:0
100,000 shares0Ordinary SharesSEC:0000899243-22-025476:0
27,500 shares@ US$9.045659.6% of flowOrdinary SharesSEC:0000899243-22-003924:0
Canonical exit: 28 Apr 2022 (T+90)
10 of 10 declarations
About Grainger David J
GRAINGER DAVID J is Responsable de l'Innovation at Centessa Pharmaceuticals plc (XNAS). He has made 10 filings in total, and in the recent filings we hold, they cover the period from 2022-02-01 to 2024-01-02, with EUR 223157 of buys and EUR 9633 of sells; the most common transaction nature is Retenue fiscale.
